Mesoblast Provides Q3 Financial Results and Corporate Update
Filed with ASX · · 8 pages · English
Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings CallIn the deck
Story so far
Earlier from Mesoblast
- Mesoblast Cells Show Disease Modifying Effects on Knee OA
- MSB partner jcr files for product approval
- Market Exclusivity Strengthened by New USA Healthcare Act
- Key Bone Repair Patent Granted in the United States
- TGA Approval To Commercially Manufacture Stem Cell Products
Later from Mesoblast
- Mesoblast Receives $6.2m From Aus Govt For R&D
- Suspension from Official Quotation
- Update on Global Heart Failure Program
- Update on Heart Failure Trial and Funding of Operations
- MSB Back Pain Results Presented, Receive Best Science Award
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast